Formulary best practice: cost containment through generic drugs
Cost containment has been a major aspect of the Affordable Care Act (ACA), with incentives for reducing hospital readmissions and pressure on drug formulary
Home » Industry News » Page 5
Cost containment has been a major aspect of the Affordable Care Act (ACA), with incentives for reducing hospital readmissions and pressure on drug formulary
The Chicago City Council unanimously approved an ordinance Wednesday, over industry objections, requiring pharmaceutical sales representatives to carry a special license. Mayor Rahm Emanuel
A hepatitis C treatment and a form of insulin led Medicare drug spending, adding up to more than $11 billion in 2015, according to
As allergy sufferers reel from the soaring costs of the EpiPen — a handheld auto-injection device of epinephrine made by Mylan that prevents life-threatening anaphylactic
Several patients have seen a significant spike in the cost of their prescription drugs over the last 10 years. It continues to be a national
Generic drugs have not been immune from some of the big price hikes their brand name counterparts have, but a report to be released Wednesday shows generic costs are
As healthcare moves to a model of any-time, any-place, continuous and personalized care, it is important to identify the key technologies that will enable this
In contrast to the technologies unlikely to make a major difference, there are multiple readily available, relatively inexpensive technologies that have the power to radically
Lowcost Pharmacy Benefit Management
877.877.5711
info@arayarx.com
PO Box 460
Latham, NY 12110